>

>

Market forecast and technology valuation for a novel immuno-oncology cell therapy

Service Areas
Therapeutic Areas

Oncology

Client Type

Pre-clinical client

Client Problems

  • A UniveristyTechnical Transfer Office wants to analyze an internal novel cell therapy product indicated for several cancers


  • They wanted to prioritize the indications and understand the potential market over 20 years for the product across different geographies, including US, EU, Japan and China.


  • The client wanted to negotiate the licensing of the technology based on the market forecast and previous licensing deals

What We Did

  • Determined the top indication for the product and created a patient flow to determine the therapeutic opportunities


  • We created a sales prediction model for the cell therapy in different geographies, accounting for loss of patent exclusivity and pricing regulations in these geographies


  • We performed sensitivity analysis to account for different variabilities


  • We analyzed comparable deals and trends in the therapeutic space

Our Results And Insight

  • Patient flow and segmentation to determine therapeutic opportunity


  • Value unwind shows impact of PTS at each stage of development


  • Sensitivity analysis to account for treated Population, growth rate and pricing


  • Analysis of relevant comparable licensing deals

See other case studies

Commercial Strategy case studies >

Oncology case studies >

Service Areas Details

Commercial Strategy (Valuation and Market Forecast)

Therapeutic Areas Details

Oncology (Cell Therapy, Hematology)

© 2019, First Principles Advisory Group. All Rights Reserved
SF Bay Area, Denver, Seattle, New York City, Cambridge
First Principles Advisory Group
1290 Howard Street Suite 323
Burlingame, CA 94010
(415) 669-5183
info@fpadvisory.net